EndoRobotics key facts
as of Oct 2026- Manufacturer of endoscopic robotic medical equipment intended to support non-invasive therapeutic procedures in gastroenterology.
- EndoRobotics is valued at approximately $16.0M as of Oct 2026 (last reported valuation).
- It has raised $35.1M; the latest was Later Stage VC ($22.3M) in Dec 2025.
- Notable investors include Tech Incubator Program for Startup, Mirae Asset Capital, Korea Technology Finance, Partners Investment, Premier Partners — 18 tracked in total.
- Status: Privately Held (backing).
EndoRobotics's last reported valuation, Aug 2021. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch EndoRobotics: the Monday email on marks, rounds and moves
EndoRobotics funding rounds
No funding rounds for EndoRobotics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs EndoRobotics
18+EndoRobotics valuation
EndoRobotics's last reported valuation was $16 million in Aug 2021. No priced round, secondary trade or fund mark has surfaced since.
EndoRobotics investors
18 investors are on record for EndoRobotics, including Tech Incubator Program for Startup, Mirae Asset Capital, Korea Technology Finance and Partners Investment.
About EndoRobotics
Manufacturer of endoscopic robotic medical equipment intended to support non-invasive therapeutic procedures in gastroenterology. The company attaches robotic arms to flexible endoscopes, facilitating precise tissue dissection, suturing, and lesion removal within the gastrointestinal tract, enabling healthcare providers to perform minimally invasive surgeries that reduce recovery time, avoid external scarring, and improve patient outcomes in digestive disease treatment.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2019
- Employees
- 46
- Website
- endorobo.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.